Indication

For the prevention of organ rejection in recipients of allogeneic kidney transplants, used in combination with other immunosuppressive medications.

Disease

After an allogeneic organ transplant, immunosuppressant drugs are administered to reduce the risk of organ rejection. These drugs work by inhibiting the production of interleukin-2, a molecule that stimulates the growth and activation of T cells, which play a crucial role in the body's adaptive immune response.

Mechanism of Action

Tacrolimus is a calcineurin inhibitor that suppresses the immune response by inhibiting the activation of T-lymphocytes.

Dosage

0.2 mg/kg/day or as directed by a registered medical practitioner.

Presentation

Strip of 10 capsules (10 strips of 10 capsules each per box).